These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28259515)

  • 21. Development of a bile acid-based newborn screen for Niemann-Pick disease type C.
    Jiang X; Sidhu R; Mydock-McGrane L; Hsu FF; Covey DF; Scherrer DE; Earley B; Gale SE; Farhat NY; Porter FD; Dietzen DJ; Orsini JJ; Berry-Kravis E; Zhang X; Reunert J; Marquardt T; Runz H; Giugliani R; Schaffer JE; Ory DS
    Sci Transl Med; 2016 May; 8(337):337ra63. PubMed ID: 27147587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease.
    Boenzi S; Deodato F; Taurisano R; Martinelli D; Verrigni D; Carrozzo R; Bertini E; Pastore A; Dionisi-Vici C; Johnson DW
    Clin Chim Acta; 2014 Nov; 437():93-100. PubMed ID: 25038260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease.
    Oliva P; Schwarz M; Mechtler TP; Sansen S; Keutzer J; Prusa AR; Streubel B; Kasper DC
    Mol Genet Metab; 2023 May; 139(1):107563. PubMed ID: 37086570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.
    Fujiwaki T; Tasaka M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):170-6. PubMed ID: 18502707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of serum cholestane-3β,5α,6β-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease.
    Kannenberg F; Nofer JR; Schulte E; Reunert J; Marquardt T; Fobker M
    J Steroid Biochem Mol Biol; 2017 May; 169():54-60. PubMed ID: 26940355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis.
    Cappellini MD; Motta I; Barbato A; Giuffrida G; Manna R; Carubbi F; Giona F
    Eur J Intern Med; 2023 Feb; 108():81-84. PubMed ID: 36443133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
    Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
    Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.
    Sidhu R; Kell P; Dietzen DJ; Farhat NY; Do AND; Porter FD; Berry-Kravis E; Vite CH; Reunert J; Marquardt T; Giugliani R; Lourenço CM; Bodamer O; Wang RY; Plummer E; Schaffer JE; Ory DS; Jiang X
    Mol Genet Metab; 2020 Apr; 129(4):292-302. PubMed ID: 32033912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases.
    Klinke G; Rohrbach M; Giugliani R; Burda P; Baumgartner MR; Tran C; Gautschi M; Mathis D; Hersberger M
    Clin Biochem; 2015 Jun; 48(9):596-602. PubMed ID: 25819840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.
    Lin N; Zhang H; Qiu W; Ye J; Han L; Wang Y; Gu X
    J Lipid Res; 2014 Feb; 55(2):338-43. PubMed ID: 24190732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholestane-3β, 5α, 6β-triol: Further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C.
    Cooper JA; Church HJ; Wu HY
    Mol Genet Metab; 2020 May; 130(1):77-86. PubMed ID: 32178982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
    Pajares S; Arias A; García-Villoria J; Macías-Vidal J; Ros E; de las Heras J; Girós M; Coll MJ; Ribes A
    J Lipid Res; 2015 Oct; 56(10):1926-35. PubMed ID: 26239048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.
    Mazzacuva F; Mills P; Mills K; Camuzeaux S; Gissen P; Nicoli ER; Wassif C; Te Vruchte D; Porter FD; Maekawa M; Mano N; Iida T; Platt F; Clayton PT
    FEBS Lett; 2016 Jun; 590(11):1651-62. PubMed ID: 27139891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.
    McGovern MM; Dionisi-Vici C; Giugliani R; Hwu P; Lidove O; Lukacs Z; Eugen Mengel K; Mistry PK; Schuchman EH; Wasserstein MP
    Genet Med; 2017 Sep; 19(9):967-974. PubMed ID: 28406489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C.
    Kubaski F; Burlina A; Polo G; Pereira D; Herbst ZM; Silva C; Trapp FB; Michelin-Tirelli K; Lopes FF; Burin MG; Brusius-Facchin AC; Netto ABO; Faqueti L; Iop GD; Poletto E; Giugliani R
    Int J Neonatal Screen; 2022 Jun; 8(3):. PubMed ID: 35892469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months.
    Wasserstein MP; Diaz GA; Lachmann RH; Jouvin MH; Nandy I; Ji AJ; Puga AC
    J Inherit Metab Dis; 2018 Sep; 41(5):829-838. PubMed ID: 29305734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Highly Sensitive and Rapid Liquid Chromatography-Tandem Mass Spectrometric Method Using a Basic Mobile Phase Additive to Determine the Characteristics of the Urinary Metabolites for Niemann-Pick Disease Type C.
    Maekawa M; Miyoshi K; Narita A; Sato T; Sato Y; Kumondai M; Kikuchi M; Higaki K; Okuyama T; Eto Y; Sakamaki H; Mano N
    Biol Pharm Bull; 2022; 45(9):1259-1268. PubMed ID: 36047194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus.
    Scarpa M; Barbato A; Bisconti A; Burlina A; Concolino D; Deodato F; Di Rocco M; Dionisi-Vici C; Donati MA; Fecarotta S; Fiumara A; Galeone C; Giona F; Giuffrida G; Manna R; Mariani P; Pession A; Scopinaro A; Spada M; Spandonaro F; Trifirò G; Carubbi F; Cappellini MD
    Intern Emerg Med; 2023 Apr; 18(3):831-842. PubMed ID: 36882619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS.
    Polo G; Burlina AP; Kolamunnage TB; Zampieri M; Dionisi-Vici C; Strisciuglio P; Zaninotto M; Plebani M; Burlina AB
    Clin Chem Lab Med; 2017 Mar; 55(3):403-414. PubMed ID: 27533120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adult psychiatric aspects of Niemann-Pick disease].
    Faludi G; Gonda X; Döme P
    Neuropsychopharmacol Hung; 2013 Jun; 15(2):95-103. PubMed ID: 23817360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.